4-[(2'-Cyano-biphenyl-4-yl)meth-yl]morpholin-4-ium hexa-fluoridophosphate.

In the cation of the title compound, C(18)H(19)N(2)O(+)·PF(6) (-), the morpholine ring adopts the usual chair conformation and the dihedral angle between the benzene rings is 67.55 (11)°. The F atoms of the anion are disordered over two orientations with a refined occupancy ratio of 0.

3,4-Dimethyl-anilinium 4-methyl-benzene-sulfonate.

In the crystal structure of the title compound, C(8)H(12)N(+)·C(7)H(7)O(3)S(-), N-H⋯O hydrogen bonds link the cations and anions into ribbons parallel to the c axis. N-H⋯S inter-actions also occur.

N-Methyl-2-oxo-1-phenyl-propan-1-aminium chloride.

In the structure of the title compound, C(10)H(14)NO(+)·Cl(-), both H atoms bound to nitro-gen are involved in N-H⋯Cl hydrogen-bonding inter-actions. These inter-actions join the cations and anions into dimeric units (two cations and two anions) with R(4) (2)(8) motifs lying about inversion centers.

Bis(1,10-phenanthroline-κN,N')(sulfato-κO,O')cobalt(II) butane-2,3-diol monosolvate.

In the title compound, [Co(SO(4))(C(12)H(8)N(2))(2)]·C(4)H(10)O(2), the Co(2+) ion has a distorted octa-hedral coordination environment composed of four N atoms from two chelating 1,10-phenanthroline ligands and two O atoms from an O,O'-bidentate sulfate anion. The dihedral angle between the two chelating N(2)C(2) groups is 83.48 (1)°.

[A study on endothelial function and inflammation factors in the first degree relatives of type 2 diabetics with normal glucose tolerance].

Objective: To study the vascular endothelial function and the level of inflammation factors in the first degree relatives (FDR) of type 2 diabetes (T2DM) patients with normal glucose tolerance and related factors.

Methods: Vascular endothelial function, plasma plasminogen activator inhibitor-1 (PAI-1), vascular cell adhesion molecule-1 (VCAM-1) and insulin active index (IAI) were measured in 57 FDR and 31 controls.

Results: As compared with the controls, there were less endothelium-dependent vasodilation [(12.